2014 Annual Meeting | 8MS.005 - Psychogenic Movement Disorders
06:30 AM - 06:50 AM |
Diagnosis and Phenomenology
Aikaterini Kompoliti, MD, FAAN |
|
06:50 AM - 07:10 AM |
Epidemiology and Investigation
Vanessa K. Hinson, MD, PhD, FAAN |
|
07:10 AM - 07:30 AM |
Presenting the Diagnosis and Prognosis
Aikaterini Kompoliti, MD, FAAN |
|
07:30 AM - 07:50 AM |
Treatment
Vanessa K. Hinson, MD, PhD, FAAN |
|
07:50 AM - 08:00 AM |
Discussion, Case Presentation
Vanessa K. Hinson, MD, PhD, FAAN, Aikaterini Kompoliti, MD, FAAN |
Aikaterini Kompoliti, MD, FAAN | Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kompoliti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Kompoliti has received research support from Emalex. Dr. Kompoliti has received research support from TEVA. Dr. Kompoliti has received research support from Theravance. Dr. Kompoliti has received research support from Ipsen. Dr. Kompoliti has received research support from Theravance. |
Vanessa K. Hinson, MD, PhD, FAAN | The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories. |